Literature DB >> 20567937

Cerulein-induced acute pancreatitis in PACAP knockout mice.

Yusuke Sakurai1, Norihito Shintani, Akihiro Arimori, Ken-Ichi Hamagami, Naoko Higuchi, Hiroaki Inoue, Kazuya Ikeda, Atsuko Hayata, Hitoshi Hashimoto, Akemichi Baba.   

Abstract

In our previous study, we reported that cerulein-induced acute pancreatitis is aggravated in pancreatic β-cell-specific pituitary adenylate cyclase-activating polypeptide (PACAP) transgenic mice, showing that an increase in pancreatic PACAP is a risk factor for progression of acute pancreatitis. Accordingly, in this study, we examined the progression of cerulein-induced acute pancreatitis in PACAP knockout (KO) mice. Unexpectedly, after cerulein, about 60% of the KO mice showed severe hypothermia below 30°C by 12 h and most of them died within 72 h. In contrast, the remaining KO and wild-type mice showed normothermia with no mortality. Thus, KO mice could be classified into two groups as hypothermic (HT-KO) and normothermic (NT-KO) to cerulein. Only HT-KO mice subsequently showed severe mortality, although both HT-KO and NT-KO mice exhibited similar susceptibility of lungs to cerulein toxicity, comparable to that in wild-type mice. Regarding pancreatitis, HT-KO mice showed ameliorated pancreatic damage without any rise in serum enzyme activities, whereas NT-KO mice exhibited a similar degree of pancreatitis to wild-type mice. Taken together, the present results indicate that lack of pancreatic PACAP did not aggravate, but rather ameliorated, cerulein-induced pancreatitis. In addition, about half of KO mice showed a novel phenotype in which cerulein caused rapid and severe hypothermia, followed by death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567937     DOI: 10.1007/s12031-010-9396-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

Review 1.  Inflammatory response on the pancreatic acinar cell injury.

Authors:  M Bhatia
Journal:  Scand J Surg       Date:  2005       Impact factor: 2.360

2.  Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.

Authors:  J Devière; O Le Moine; J L Van Laethem; P Eisendrath; A Ghilain; N Severs; M Cohard
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

3.  A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition.

Authors:  Maxim S Petrov; Mikhail V Kukosh; Nikolay V Emelyanov
Journal:  Dig Surg       Date:  2006-12-12       Impact factor: 2.588

4.  Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats.

Authors:  You-Dai Chen; Zong-Guang Zhou; Zhao Wang; Hong-Kai Gao; Wen-Wei Yan; Cun Wang; Gao-Ping Zhao; Xiao-Hui Peng
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

5.  Pathogenic role of myeloperoxidase in acute pancreatitis.

Authors:  Serge Chooklin; Andriy Pereyaslov; Ihor Bihalskyy
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2009-12

6.  PACAP and VIP stimulate enzyme secretion in rat pancreatic acini via interaction with VIP/PACAP-2 receptors: additive augmentation of CCK/carbachol-induced enzyme release.

Authors:  W E Schmidt; J Seebeck; M Höcker; R Schwarzhoff; H Schäfer; H Fornefeld; C Morys-Wortmann; U R Fölsch; W Creutzfeldt
Journal:  Pancreas       Date:  1993-07       Impact factor: 3.327

7.  Effect of ligands that increase cAMP on caerulein-induced zymogen activation in pancreatic acini.

Authors:  Z Lu; T R Kolodecik; S Karne; M Nyce; F Gorelick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-07-24       Impact factor: 4.052

8.  Over-expression of pancreatic pituitary adenylate cyclase-activating polypeptide (PACAP) aggravates cerulein-induced acute pancreatitis in mice.

Authors:  Ken-ichi Hamagami; Yusuke Sakurai; Norihito Shintani; Naoko Higuchi; Kazuya Ikeda; Hitoshi Hashimoto; Akinobu Suzuki; Hiroshi Kiyama; Akemichi Baba
Journal:  J Pharmacol Sci       Date:  2009-08       Impact factor: 3.337

9.  Effect of secretin and caerulein in canine pancreas: relation to prostaglandins.

Authors:  T Homma; K U Malik
Journal:  Am J Physiol       Date:  1983-06

Review 10.  Receptor strategies in pancreatitis.

Authors:  J H Grendell
Journal:  Yale J Biol Med       Date:  1992 Sep-Oct
View more
  5 in total

Review 1.  Trophic effects of PACAP on pancreatic islets: a mini-review.

Authors:  Yusuke Sakurai; Norihito Shintani; Atsuko Hayata; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Mol Neurosci       Date:  2010-07-20       Impact factor: 3.444

Review 2.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

3.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

Review 4.  Protective Effects of PACAP in Peripheral Organs.

Authors:  Denes Toth; Edina Szabo; Andrea Tamas; Tamas Juhasz; Gabriella Horvath; Eszter Fabian; Balazs Opper; Dora Szabo; Grazia Maugeri; Agata G D'Amico; Velia D'Agata; Viktoria Vicena; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

Review 5.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.